More than 500 Geisinger MyCode participants receive clinical results from exome sequencing; most risks previously unknown
BioTech Gate,
DANVILLE, Pa., Nov. 30, 2017 /PRNewswire-USNewswire/ -- Geisinger is today observing an initial milestone of reaching more than…